Metabolic Changes in Patients With Chronic Cardiopulmonary Disease
NCT02550808 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2015-09-16
Summary
This study aims to evaluate prevalence of sarcopenia and cachexia in patients with chronic cardiopulmonary disease. The investigators will also investigate metabolic disorders like glucose metabolism, presence of metabolic syndrome, body composition and histological changes in skeletal muscle and body fat. Finally, patients will be followed for clinical endpoints.
Conditions
Sponsors & Collaborators
-
University of Ljubljana
collaborator OTHER -
General Hospital Murska Sobota
collaborator OTHER -
Maastricht University
collaborator OTHER -
General and Teaching Hospital Celje
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-03-31
- Primary Completion
- 2016-07-31
- Completion
- 2017-12-31
Countries
- Slovenia
Study Locations
More Related Trials
-
Is COPD a Risk Factor for Cardiovascular Disease?
NCT02162095 ·Status: COMPLETED
-
Pulmonary Function, Chronic Obstructive Pulmonary Disease (COPD) Prevalence, and Systemic Inflammation in Chronic Heart Failure With or Without COPD
NCT01429376 ·Status: COMPLETED ·Phase: NA
-
Serum, Plasma, DNA and Tissue Bank in Chronic Obstructive Pulmonary Disease and Lung Cancer
NCT00858520 ·Status: UNKNOWN
-
Assessment of Comorbidities in Chronic Obstructive Pulmonary Disease (COPD) in European Symptomatic Subjects From Primary Care
NCT01516528 ·Status: COMPLETED
-
Role of Systemic Inflammation in Increase of Cardio-vascular Risk in Chronic Obstructive Pulmonary Disease
NCT02888886 ·Status: COMPLETED ·Phase: NA
-
Prediction of Pulmonary Rehabilitation Outcomes in Patients With Chronic Respiratory Disease Based on Metabolomics: a Prospective Cohort Study
NCT05681364 ·Status: UNKNOWN
-
Feasibility of Proteomics in Chronic Lung Disease With Sarcopenia
NCT06312774 ·Status: NOT_YET_RECRUITING
-
Genetic and Environmental Determinants That Control Metabolism in Pulmonary Hypertension
NCT02594917 ·Status: COMPLETED
-
Muscle Strength and Exercise Capacity in Sarcoidosis Patients
NCT00854672 ·Status: COMPLETED
-
The Impact of Sarcopenia on COPD Exacerbation Admission Outcome and Further Exacerbation Risk
NCT04885933 ·Status: COMPLETED
-
Effects of Obesity on COPD
NCT06474858 ·Status: COMPLETED
-
Biomarkers of Early Chronic Obstructive Pulmonary Disease (COPD) in Smokers - Longitudinal Study
NCT02076061 ·Status: COMPLETED
-
Nutritional Assessment in Idiopathic Pulmonary Fibrosis
NCT03770845 ·Status: COMPLETED
-
Respiratory and Cardiovascular Alterations in Patients With Chronic Obstructive Pulmonary Disease
NCT06072690 ·Status: RECRUITING
-
The Significance of Circulating Microvesicles in Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease
NCT05250128 ·Status: UNKNOWN
-
Evaluation of COPD (Chronic Obstructive Pulmonary Disease) to Longitudinally Identify Predictive Surrogate Endpoints
NCT00292552 ·Status: COMPLETED
-
Energy Metabolism for the Patients With Pulmonary Mycobacterium Avium Complex
NCT03550820 ·Status: COMPLETED
-
Diagnostic and Prognostic Value of New Biomarkers in Patients With Heart Disease
NCT01374880 ·Status: UNKNOWN
-
Assessment of Long-term Sequelae of Coronavirus Disease 2019 (COVID-19) Pneumonia With Chest CT and Pulmonary Function Tests
NCT05835128 ·Status: UNKNOWN
-
Pulmonary Vascular Changes in Early Chronic Obstructive Pulmonary
NCT01397721 ·Status: COMPLETED
-
A Study to Characterize the Disease Behavior of Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD) During the Peri-Diagnostic Period
NCT03261037 ·Status: COMPLETED ·Phase: NA
-
Seasonal Trends in Pneumococcal Carriage in COPD Patients
NCT02535546 ·Status: COMPLETED
-
Metabolomic Biomarkers Evaluation in Pulmonary Fibrosis
NCT06974799 ·Status: COMPLETED
-
Multiorgan Pathology in Chronic Obstructive Pulmonary Disease (COPD)
NCT00864994 ·Status: UNKNOWN
-
Micro-environment Involvement in Muscle Alteration Induced
NCT04448626 ·Status: COMPLETED